Detection and identification of potential biomarkers of breast cancer.
about
Reproducibility of SELDI Spectra Across Time and LaboratoriesAvailability of MudPIT data for classification of biological samplesEarly diagnostic protein biomarkers for breast cancer: how far have we come?Discrimination analysis of mass spectrometry proteomics for cervical cancer detection.Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.The application of SELDI-TOF-MS in clinical diagnosis of cancersSELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects.New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses.Improved classification of breast cancer peptide and protein profiles by combining two serum workup proceduresIdentification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factorsProteomic serum biomarkers and their potential application in cancer screening programs.Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma.Identification of osteoarthritis biomarkers by proteomic analysis of synovial fluid.Protein biomarkers for the early detection of breast cancer.Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast CancerNon-invasive proteomics-thinking about personalized breast cancer screening and treatmentPersonalized medicine in screening for malignant disease: a review of methods and applications.Long intergenic non-coding RNA APOC1P1-3 inhibits apoptosis by decreasing α-tubulin acetylation in breast cancerPrediction of metastasis and recurrence in colorectal cancer based on gene expression analysis: ready for the clinic?Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometryDiagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometryStatistical issues in quality control of proteomic analyses: good experimental design and planning.Multi-biomarker pattern for tumor identification and prognosis.Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.Identification of differentially expressed inflammatory factors in Wilms tumors and their association with patient outcomes.Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.
P2860
Q30484977-FE43384B-BF99-4D22-BB8F-5D82B8462980Q30585972-7D9098D5-FA17-487B-9161-3AEC95DC1598Q31043570-BB268F44-847E-46AD-B23D-F5110CAC51BBQ33747964-6F3E09A8-E145-469B-A102-C3B7844B69B7Q33799359-9450EEDB-BF14-4394-B7B4-CD81029753A6Q33892389-293B2811-61F0-48A5-8E0E-31A1DFAC68D3Q33936575-0E77B4CE-4621-436C-8CDD-0D6F6BEAE33AQ33940289-246CC96B-2258-44FE-A6D3-62632838E649Q34045656-E40457ED-8D75-481B-97AE-6E76252397D3Q34086346-8725001F-AF5A-4CE4-9373-F0B00F20D5B3Q34319541-6ECCBFD1-6CE2-44F3-B463-CD8B4409A593Q34327104-348AF810-2830-45EC-95D6-B7CA14333FCEQ34358608-EE4727ED-5F73-449D-B4CC-A598B959CD6DQ34395996-C02641BE-0B11-4E46-BB71-5CA5DEBD5967Q34411956-1377B8ED-428C-47BD-B9B8-D9E7AF9BD673Q34548953-D8A0FD27-CEA3-4EDD-8CAC-6F944DF9B158Q35367572-A48A92DE-DB4A-48AB-88AC-BABC65F9DB50Q35981747-EFDEC364-4950-4958-870E-6A0313CD63CCQ36117711-C488E3EB-68CF-4EFE-A99C-37E0EB9C3F5FQ36641610-4DD96FB2-ABD7-41AC-8E64-EC91C80A7580Q37030345-82B5313D-1C53-4EE0-B695-A4699ED6E713Q37137352-E440379A-C3F3-44A8-ACBD-19C039858827Q37174708-C07E9034-284E-41CC-A905-542D856008D1Q37187745-3FD69487-52D9-4218-BB18-1E1584DC37A6Q37836674-C03C5F12-E76C-488E-ACBC-FB7E45BB6F53Q37890322-7CC087CF-9063-4BE8-ADB5-A75406F41324Q38068925-32F73F7C-3D0A-4A33-B3D3-FF8247DA7AD9Q40979439-1E04A9C0-8B19-4EAE-BA59-746DB26D65A3Q44190698-BF6D9E55-8F10-4898-A5B5-BF1D298DF1A0
P2860
Detection and identification of potential biomarkers of breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Detection and identification of potential biomarkers of breast cancer.
@ast
Detection and identification of potential biomarkers of breast cancer.
@en
Detection and identification of potential biomarkers of breast cancer.
@nl
type
label
Detection and identification of potential biomarkers of breast cancer.
@ast
Detection and identification of potential biomarkers of breast cancer.
@en
Detection and identification of potential biomarkers of breast cancer.
@nl
prefLabel
Detection and identification of potential biomarkers of breast cancer.
@ast
Detection and identification of potential biomarkers of breast cancer.
@en
Detection and identification of potential biomarkers of breast cancer.
@nl
P2093
P1476
Detection and identification of potential biomarkers of breast cancer.
@en
P2093
Jiachen Wang
Jiaxiang Wang
Mengquan Li
Qiuliang Liu
Yingzhong Fan
P2860
P2888
P304
P356
10.1007/S00432-010-0775-1
P577
2010-03-17T00:00:00Z